NEWBORN SCREENING OF INFANTS AND NEWBORNS WITH CONGENITAL HYPOTHYROIDISM
Associate Professor Michelle Jack
Clinical Practice & Co-Lead Doctor of Medicine
Bond University, Queensland, Australia
RESEARCHER PROFILE
Filmed in Robina, Queensland | July 2024
Michelle Jack is Associate Professor of Clinical Practice, Faculty of Health Sciences & Medicine at Bond University, QLD and co-Head of Paediatrics and a Paediatric Endocrinologist at Lismore Base Hospital in NSW. She graduated from Medicine at the University of Queensland with first class honours and the University Gold Medal and has a PhD in hyperinsulinism from the University of QLD. She has postgraduate qualifications in higher education and is a fellow of the higher education academy.
Assoc Prof Jack is an experienced leader and practitioner in the healthcare, research and higher education sectors. Career highlights include: Head of Department Paediatric Endocrinology, Royal North Shore Hospital; Academic Lead Education & Partnerships, University Centre for Rural Health, University of Sydney; Head of the Beta Cell Laboratory, Kolling Institute; Chair Australasian Paediatric Endocrine Group scientific program organising committee and Co-Chair international scientific program organising committees; Chair Northern Sydney Adolescent Committee; International Research Fellowship, Juvenile Diabetes Research Foundation, Head of Research, Impact Institute.
Assoc Prof Jack is passionate about the health and wellbeing of children and adolescents, with diverse research areas including the impacts of family friendly workplace initiatives, screening and management of thyroid disorders in infants and children. She supports her First Nations colleagues on Indigenous-led research projects funded by the Medical Research Future Fund, aiming to improve the social and emotional wellbeing of First Nations Children. Through her clinical and academic roles, Assoc Prof Jack hopes to make a positive difference to the health and well-being of children and their families.
-
Healthier Food Retail
Professor Anna Peeters AM is a globally recognised public health leader whose career has spanned academia, policy and health system reform, with a strong focus on prevention and health equity. She is the CEO of VicHealth, bringing decades of experience in epidemiology, population health and evidence-based health promotion.
-
Applying artificial intelligence to medical imaging for cardiovascular disease detection
Parmida is a software engineer and biomedical scientist whose research focuses on translating novel medical imaging technologies into clinical practice to improve the diagnosis and management of cardiovascular disease.
Her current work applies advanced deep learning techniques to retinal polarization-sensitive optical coherence tomography (PS-OCT) imaging, aiming to generate clinically meaningful biomarkers and predictions of cardiovascular disease. Parmida’s collaboration partners include Fiona Stanley Hospital in Murdoch, Western Australia.
-
Personalised approaches to lung therapy
Dr. Adams’ research focus is on lung cancer, which is the deadliest of all cancers worldwide. He is working towards developing personalised approaches to pinpoint a therapy that is going to be most effective for the person with that disease. Dr. Adams’ research is focusing on chemotherapy and targeted therapy, and he is trying to identify upfront which of those tumours are likely to be resistant to the therapy. He then identifies strategies that will resensitize or increase the sensitivity of the tumour to the standard of care that is targeted therapy or chemotherapy.
